Visualization and quantification of intestinal transit and motor function by real‐time tracking of 19F labeled capsules in humans

A combined 19F and 1H MRI framework for the assessment of human intestinal transit and motor function is presented. This framework consists of silicone coated polychlorotrifluoroethylene capsules filled with perfluoro‐[15]‐crown‐5‐ether as 19F marker, a flexible 19F surface coil and a 19F projection imaging sequence, allowing for real‐time tracking of a single or multiple capsules. The capsules (length 11.5 mm, Ø 7.2 mm) contain 140 μL perfluoro‐[15]‐crown‐5‐ether and were tested for cytotoxicity and leakage prior to oral administration. A balanced SSFP projection sequence was implemented, yielding a temporal resolution of 133 ms. Optional multi‐frequency excitation, allowing for interleaved tracking of differently labeled 19F capsules, was incorporated. The passage of the 19F capsules through intestinal sections was monitored in two healthy volunteers. Capsule coordinates were successfully coregistered with anatomical reference scans. Intestinal motility, residence times, lengths and forward velocities were determined. Simultaneous tracking of two capsules allowed for the assessment of peristaltic patterns with correction for respiratory motion. By providing the means for real‐time multiple capsule tracking and high resolution anatomical imaging, the presented multinuclear imaging framework has the potential to provide important supplemental information for physiological and pharmaceutical research. Magn Reson Med, 2011. © 2011 Wiley‐Liss, Inc.

[1]  H. Parkman,et al.  Wireless Capsule Motility: Comparison of the SmartPill® GI Monitoring System with Scintigraphy for Measuring Whole Gut Transit , 2009, Digestive Diseases and Sciences.

[2]  M. Camilleri,et al.  Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. , 2006, Gastroenterology.

[3]  Pascal Spincemaille,et al.  Kalman filtering for real‐time navigator processing , 2008, Magnetic resonance in medicine.

[4]  Vikram D Kodibagkar,et al.  19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. , 2005, Current medicinal chemistry.

[5]  V. Schlageter,et al.  Colonic movements in healthy subjects as monitored by a Magnet Tracking System , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[6]  V. Schlageter,et al.  Magnetic pill tracking: a novel non‐invasive tool for investigation of human digestive motility , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[7]  R. Hauser,et al.  Duodenal levodopa infusion for the treatment of Parkinson’s disease , 2007, Expert opinion on pharmacotherapy.

[8]  Basil Künnecke,et al.  Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance , 2002, Magnetic resonance in medicine.

[9]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[10]  M. Krafft,et al.  Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. , 2001, Advanced drug delivery reviews.

[11]  Fernando Vilariño,et al.  Intestinal Motility Assessment With Video Capsule Endoscopy: Automatic Annotation of Phasic Intestinal Contractions , 2010, IEEE Transactions on Medical Imaging.

[12]  S. Caruthers,et al.  Molecular MR Imaging with Paramagnetic Perfluorocarbon Nanoparticles , 2008 .

[13]  E. Benarroch,et al.  Neural control of the gastrointestinal tract: Implications for Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[14]  R. Fisher,et al.  Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[15]  Hansen Mb,et al.  Small intestinal manometry. , 2002 .

[16]  E. Quigley,et al.  Gastric and small intestinal motility in health and disease. , 1996, Gastroenterology clinics of North America.

[17]  M. Hansen,et al.  Small intestinal manometry. , 2002, Physiological research.

[18]  S. Flaim Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[19]  R. Mattrey,et al.  Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trial. , 1994, Radiology.

[20]  Lutz Trahms,et al.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.

[21]  Samuel A Wickline,et al.  Quantitative magnetic resonance fluorine imaging: today and tomorrow. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[22]  H. Mönnikes,et al.  Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  May C. Chen An Illustrated Guide to Gastrointestinal Motility , 1989, The Yale Journal of Biology and Medicine.

[24]  E. Quigley,et al.  Disturbances in small bowel motility. , 1999, Bailliere's best practice & research. Clinical gastroenterology.

[25]  T. Dinan,et al.  Irritable bowel syndrome: towards biomarker identification. , 2009, Trends in molecular medicine.

[26]  M. Bogataj,et al.  Gastric emptying of non-disintegrating solid drug delivery systems in fasted state: relevance to drug dissolution , 2010, Expert opinion on drug delivery.

[27]  R. Mason,et al.  Comparison of 1H blood oxygen level–dependent (BOLD) and 19F MRI to investigate tumor oxygenation , 2009, Magnetic resonance in medicine.

[28]  S. Caruthers,et al.  1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. , 2005, Current topics in developmental biology.

[29]  Philippe C. Cattin,et al.  Intensity-based elastic registration incorporating anisotropic landmark errors and rotational information , 2009, International Journal of Computer Assisted Radiology and Surgery.

[30]  C. Gorter,et al.  Negative result of an attempt to observe nuclear magnetic resonance in solids , 1942 .

[31]  M. Camilleri,et al.  Pathophysiology as a basis for understanding symptom complexes and therapeutic targets , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[32]  Clive G. Wilson,et al.  Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.